Literature DB >> 142068

Interactions of alpha1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness.

K M Chiu, R F Mortensen, A P Osmand, H Gewurz.   

Abstract

Alpha1-acid glycoprotein (AAG) is a constituent of normal serum which is elevated in concentration in the acute phase of inflammation; its physical and chemical properties have been defined but its biological function is uncertain. In the present study, the effect of AAG on the proliferative response of lymphocytes to several different stimuli was determined. For this purpose AAG was prepared by precipitation of human ascites fluid with sulphosalicylic acid and passage of the supernate through SP-Sephadex; the eluted protein migrated as a single band during immunoelectrophoresis, polyacrylamide gel electrophoresis and chromatography on Bio-Gel-A-1-5 m in 6 M guanidine HCl. This AAG was found to markedly inhibit the proliferative response of human peripheral blood lymphocytes to PHA; it also inhibited blastogenesis induced by Con A and PWM, but to a lesser extent. AAG was not cytotoxic to lymphocytes, and its inhibitory effects were reversed at higher mitogen concentrations. Lymphocytes preincubated with AAG remained less reactive to PHA indicating that, although AAG appeared to react with PHA, its effect was directed predominantly to the cell. Further, AAG markedly inhibited the mixed lymphocyte response, and this effect was directed to the responder cells. Thus, AAG is another acute phase reactant with the ability to modulate lymphocyte responsiveness.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 142068      PMCID: PMC1445435     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Comparative antigenicity of native and "desialized" orosomucoid in rabbits.

Authors:  E ATHINEOS; M THORNTON; R J WINZLER
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

2.  Steroid-protein interactions. VII. Interactions of progesterone and corticosteroids with human plasma proteins determined by multiple equilibrium dialysis.

Authors:  U WESTPHAL; B D ASHLEY; G L SELDEN
Journal:  Arch Biochem Biophys       Date:  1961-03       Impact factor: 4.013

3.  Effect of human alpha 1-acid glycoprotein on blood coagulation.

Authors:  I M NILSSON; I YAMASHINA
Journal:  Nature       Date:  1958-03-08       Impact factor: 49.962

4.  Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

5.  Studies on the mucoproteins of human plasma. V. Isolation and characterization of a homogeneous mucoprotein.

Authors:  H E WEIMER; J W MEHL; R J WINZLER
Journal:  J Biol Chem       Date:  1950-08       Impact factor: 5.157

6.  Serum-derived immunosuppressive substances. I. Partial purification and range of action.

Authors:  F Miller
Journal:  Transplantation       Date:  1976-03       Impact factor: 4.939

7.  Effects of C-reactive protein on the lymphoid system. II. Inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes.

Authors:  R F Mortensen; H Gewurz
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

8.  Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP.

Authors: 
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

9.  Mass isolation and culture of rat kupffer cells.

Authors:  A C Munthe-Kaas; T Berg; P O Seglen; R Seljelid
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

10.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

View more
  32 in total

1.  Expression of cyclooxygenase-2, alpha 1-acid-glycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosy.

Authors:  Mayra Silva Miranda; Kendy Wek Rodríguez; Erasmo Martínez Cordero; Oscar Rojas-Espinosa
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

2.  Localization of DNA sequences involved in dexamethasone-dependent expression of the rat alpha 1-acid glycoprotein gene.

Authors:  H Baumann; L E Maquat
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

3.  Acute-phase response of plasma protein synthesis during experimental inflammation in neonatal rats.

Authors:  T Thomas; G Schreiber
Journal:  Inflammation       Date:  1985-03       Impact factor: 4.092

4.  Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levels.

Authors:  N Jauregizar; R Calvo; E Suarez; A Quintana; E Raczka; J C Lukas
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

5.  Structure of the rat alpha 1-acid glycoprotein gene.

Authors:  Y C Liao; J M Taylor; J L Vannice; G A Clawson; E A Smuckler
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

6.  Inhibition of lymphocyte DNA synthesis by plasma from patients with Kawasaki disease.

Authors:  J Hirao; N Izumi; Y Nagai; N Homma
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

7.  Immunologic and genetic factors influencing reproduction. A review.

Authors:  T J Gill; C F Repetti
Journal:  Am J Pathol       Date:  1979-05       Impact factor: 4.307

8.  Modulation of alpha 1-acid glycoprotein (AGP) gene induction following honey bee venom administration to adjuvant arthritic (AA) rats; possible role of AGP on AA development.

Authors:  M Yiangou; C Konidaris; P Victoratos; L Hadjipetrou-Kourounakis
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

9.  Prevalence of tri- and tetraantennary glycans of human alpha 1-acid glycoprotein in release of macrophage inhibitor of interleukin-1 activity.

Authors:  P N Bories; J Feger; N Benbernou; J D Rouzeau; J Agneray; G Durand
Journal:  Inflammation       Date:  1990-06       Impact factor: 4.092

10.  Interaction of an acute phase reactant, alpha 1-acid glycoprotein (orosomucoid), with the lymphoid cell surface: a model for non-specific immune suppression.

Authors:  D A Cheresh; D H Haynes; J A Distasio
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.